`
`People *
`
`DAVID
`
`MOTTOLA, PhD
`
`Q
`
`Join now
`
`DAVID’S public profile badge
`Includethis Linkedin profile on other
`
`websites e DAVID MOTTOLA, PhD
`
`Vice President, Clinical
`Development at Gossamer Bio
`University of North Carolina at
`ChapelHill
`
`il
`
`DAVID MOTTOLA, PhD
`Vice President, Clinical Developmentat GossamerBio
`San Diego,California, United States . 255 connections
`aceled
`ign
`
`@ Whensigningin, you canchooseto viewtheprofile in private mode.
`
`
`
`University of North Carolina at
`ChapelHill
`
`Linkedifl
`
`iew profile badges
`
`About
`PRODUCT DEVELOPMENT # CORPORATE STRATEGY + LICENSING/BUSINESS DEVELOPMENT
`
`Anagile, solution-oriented senior-level Research & Developmentleader, he has a track record of
`career achievementsthat spans the full scope of product development, business development,
`corporate strategy, and financial management for biopharmaceutical companies.
`
`He has a reputation as a quality deliverables champion with strong interpersonalskills, a high level of
`personalinitiative and whothinksanalytically and proactively to achieve organizational goals in both
`start-up and established organizations. He is known for his keen insights regarding technical
`execution of product developmentsandportfolio management. Asaninnovator, he has excellent
`problem-solving abilities to readily address emerging challenges, while maintaining rigorous quality
`standards and compliance with regulatory requirements. His broad executive leadership experience
`provides acumensto drive company growth and success.
`
`In addition, he has provided expert consulting and advisory services to small- and medium-sized
`biopharma companiestofacilitate regulatory filings, surmount regulatory challenges and define
`clinical strategies and plans.
`
`A few representative examples of his successes related to organizational leadership, product
`development, and businessstrategy and partnership developmentinclude:
`xGuided United Therapeutics’ (UT)clinical affairs and product developmentfrom start-up with zero
`revenue to ~$900Min revenue.
`Developed and advanced multiple products at UT to drive companyfrom no approved productto a
`four approved-productportfolio, with a corresponding 1600% revenueincrease in 10 years.
`Created and advanced strategies to develop GeneBiology’s lead product, raise capital and financial
`bootstrapping, and cultivate relationships with key partners.
`xGuided 5 NDAapprovals and 3 Orphan Drug Designation approvals with the FDA
`Demonstrated R&D, Business & Leadership Strengths:
`RESEARCH & DEVELOPMENT(R&D)| SCIENTIFIC STRATEGY| CLINICAL OPERATIONS & SCIENCES|
`DRUG PORTFOLIO MANAGEMENT| QUALITY & PROCESS IMPROVEMENT| TEAM BUILDING &
`ENGAGEMENT| OUT-LICENSING| IN-LICENSING | FDA REGISTRATION & APPROVAL
`
`Activity
`
`
`
`Nice article
`Liked by DAVID MOTTOLA, PhD
`
`#GOSSis proud to support #CCAwarenessWeek & our partners at
`@CrohnsColitisFn by continuing our #Thread2Patients campaign through
`to Dec.7th...
`Liked by DAVID MOTTOLA, PhD
`
`“to listen carefully to the wisdom of patients” -- Sandy, Director of New
`ProductPlanning #Thread2Patients #phawarenessmonth #phaware
`PHAWARE...
`Liked by DAVID MOTTOLA,PhD
`
`ign in to see all activity
`
`Education
`
`University of North Carolina at Chapel Hill
`Doctorof Philosophy (PhD) - Pharmacology
`
`State University of New York at Binghamton
`Bachelor of Science (BS)- Biology/Biological Sciences, General
`
`
`
`View DAVID'S full profile
`@® See who you know in common
`S| Getintroduced
`48 Contact DAVIDdirectly
`
`Signin to view full pr
`
`Linked[fJ] ©2021 About Accessibility
`
`User Agreement
`
`Privacy Policy
`
`Cookie Palicy Copyright Policy
`
`Brand Policy Guest Controls
`
`Community Guidelines
`
`Language ~~
`
`
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
